NCT00000699View on ClinicalTrials.gov

A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Inosine pranobex

DRUG

Ribavirin

Trial Locations (1)

20037

George Washington Univ Med Ctr, Washington D.C.

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH